| P2093 | author name string | E D Kharasch | |
| P2860 | cites work | Identification of the enzyme responsible for oxidative halothane metabolism: implications for prevention of halothane hepatitis | Q28610007 |
| | New Insights into the Mechanism of Methoxyflurane Nephrotoxicity and Implications for Anesthetic Development (Part 2) | Q29039700 |
| | New Insights into the Mechanism of Methoxyflurane Nephrotoxicity and Implications for Anesthetic Development (Part 1) | Q29306619 |
| | Human Kidney Methoxyflurane and Sevoflurane Metabolism | Q29544100 |
| | Metabolism of trichloroethylene | Q33916680 |
| | Formation and toxicity of anesthetic degradation products | Q36098996 |
| | Inhalation anaesthesia: from diethyl ether to xenon | Q37050372 |
| | The invention and development of enflurane, isoflurane, sevoflurane, and desflurane | Q37091697 |
| | The immunologic and metabolic basis of drug hypersensitivities | Q39647228 |
| | Biotransformation of sevoflurane | Q40374140 |
| | Human halothane metabolism, lipid peroxidation, and cytochromes P(450)2A6 and P(450)3A4. | Q43502907 |
| | Mathematical modeling of carbon monoxide exposures from anesthetic breakdown: effect of subject size, hematocrit, fraction of inspired oxygen, and quantity of carbon monoxide | Q43618351 |
| | Plasma fluoride concentrations during and after prolonged anesthesia: a comparison of halothane and isoflurane | Q45254212 |
| | Influence of sevoflurane on the metabolism and renal effects of compound A in rats | Q46818990 |
| | Methoxyflurane revisited: tale of an anesthetic from cradle to grave | Q48585757 |
| | Compound A uptake and metabolism to mercapturic acids and 3,3,3-trifluoro-2-fluoromethoxypropanoic acid during low-flow sevoflurane anesthesia: biomarkers for exposure, risk assessment, and interspecies comparison. | Q51434234 |
| | Mechanistic aspects of carbon monoxide formation from volatile anesthetics. | Q51496987 |
| | Plasma inorganic fluoride concentrations during and after prolonged (greater than 24 h) isoflurane sedation: effect on renal function. | Q51701779 |
| | Fluorinated anaesthetic nephrotoxicity: an update. | Q51843698 |
| | Isoniazid-induced enflurane defluorination in humans. | Q51860510 |
| | HALOTHANE HEPATITIS | Q56453619 |
| | Methoxyflurane Nephrotoxicity | Q57407903 |
| | Pentahaloethane-based chlorofluorocarbon substitutes and halothane: correlation of in vivo hepatic protein trifluoroacetylation and urinary trifluoroacetic acid excretion with calculated enthalpies of activation | Q67589136 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 158-162 | |
| P577 | publication date | 2008-05-28 | |
| P1433 | published in | Clinical Pharmacology & Therapeutics | Q1101529 |
| P1476 | title | Adverse drug reactions with halogenated anesthetics | |
| P478 | volume | 84 | |